Tremblay MR - Search Results

1

Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase.

Poirier D, Boivin RP, Tremblay MR, Bérubé M, Qiu W, Lin SX. Poirier D, et al. Among authors: tremblay mr. J Med Chem. 2005 Dec 29;48(26):8134-47. doi: 10.1021/jm058235e. J Med Chem. 2005. PMID: 16366595

2

A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinity.

Qiu W, Campbell RL, Gangloff A, Dupuis P, Boivin RP, Tremblay MR, Poirier D, Lin SX. Qiu W, et al. Among authors: tremblay mr. FASEB J. 2002 Nov;16(13):1829-31. doi: 10.1096/fj.02-0026fje. Epub 2002 Sep 5. FASEB J. 2002. PMID: 12223444

3

Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol.

Tremblay MR, Boivin RP, Luu-The V, Poirier D. Tremblay MR, et al. J Enzyme Inhib Med Chem. 2005 Apr;20(2):153-63. doi: 10.1080/14756360500043307. J Enzyme Inhib Med Chem. 2005. PMID: 15968820 Free article.

4

Synthesis of 16-(bromoalkyl)-estradiols having inhibitory effect on human placental estradiol 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD type 1).

Tremblay MR, Auger S, Poirier D. Tremblay MR, et al. Bioorg Med Chem. 1995 May;3(5):505-23. doi: 10.1016/0968-0896(95)00041-e. Bioorg Med Chem. 1995. PMID: 7648200

5

C16 and C17 derivatives of estradiol as inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1: chemical synthesis and structure-activity relationships.

Sam KM, Boivin RP, Tremblay MR, Auger S, Poirier D. Sam KM, et al. Among authors: tremblay mr. Drug Des Discov. 1998 May;15(3):157-80. Drug Des Discov. 1998. PMID: 9689499

6

Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation.

Tremblay MR, Poirier D. Tremblay MR, et al. J Steroid Biochem Mol Biol. 1998 Aug;66(4):179-91. doi: 10.1016/s0960-0760(98)00043-0. J Steroid Biochem Mol Biol. 1998. PMID: 9744515

7

Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities.

Tremblay MR, Luu-The V, Leblanc G, Noël P, Breton E, Labrie F, Poirier D. Tremblay MR, et al. Bioorg Med Chem. 1999 Jun;7(6):1013-23. doi: 10.1016/s0968-0896(98)00260-0. Bioorg Med Chem. 1999. PMID: 10428369

8

Parallel solid-phase synthesis of a model library of 7alpha-alkylamide estradiol derivatives as potential estrogen receptor antagonists.

Tremblay MR, Simard J, Poirier D. Tremblay MR, et al. Bioorg Med Chem Lett. 1999 Oct 4;9(19):2827-32. doi: 10.1016/s0960-894x(99)00487-4. Bioorg Med Chem Lett. 1999. PMID: 10522700

9

Inhibitors of type II 17beta-hydroxysteroid dehydrogenase.

Poirier D, Bydal P, Tremblay MR, Sam KM, Luu-The V. Poirier D, et al. Among authors: tremblay mr. Mol Cell Endocrinol. 2001 Jan 22;171(1-2):119-28. doi: 10.1016/s0303-7207(00)00427-5. Mol Cell Endocrinol. 2001. PMID: 11165020

10

Chemical synthesis of 16beta-propylaminoacyl derivatives of estradiol and their inhibitory potency on type 1 17beta-hydroxysteroid dehydrogenase and binding affinity on steroid receptors.

Tremblay MR, Lin SX, Poirier D. Tremblay MR, et al. Steroids. 2001 Nov;66(11):821-31. doi: 10.1016/s0039-128x(01)00116-7. Steroids. 2001. PMID: 11576622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters